271 related articles for article (PubMed ID: 8885499)
1. Gemcitabine for lung cancer.
Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
[No Abstract] [Full Text] [Related]
2. Gemcitabine--a major advance?
Thomas A; Steward WP
Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
[No Abstract] [Full Text] [Related]
3. Commentary on "Gemcitabine: single-agent and combination therapy in non-small cell lung cancer". The Oncologist 1999;4:241-251.
Edelman MJ
Oncologist; 1999; 4(3):252-5. PubMed ID: 10394592
[No Abstract] [Full Text] [Related]
4. The emerging role of gemcitabine in lung cancer: part I.
Bunn PA
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
[No Abstract] [Full Text] [Related]
5. Veno-occlusive disease of the liver induced by gemcitabine.
Dobbie M; Hofer S; Oberholzer M; Herrmann R
Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
[No Abstract] [Full Text] [Related]
6. An unusual case of gemcitabine-induced radiation recall.
Squire S; Chan M; Feller E; Mega A; Gold R
Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
[No Abstract] [Full Text] [Related]
7. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418
[No Abstract] [Full Text] [Related]
8. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
Hansen HH; Sørensen JB
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic-uremic syndrome caused by gemcitabine.
Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
[No Abstract] [Full Text] [Related]
10. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.
Lund B; Ryberg M; Petersen PM; Anderson H; Thatcher N; Dombernowsky P
Ann Oncol; 1994 Nov; 5(9):852-3. PubMed ID: 7848889
[No Abstract] [Full Text] [Related]
11. Gemcitabine in non-small cell lung cancer.
Sørensen JB
Lung Cancer; 1995 Apr; 12 Suppl 1():S173-5. PubMed ID: 7551926
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for advanced non-small cell lung cancer (NSCLC).
Manegold C
Lung Cancer; 2002 Dec; 38 Suppl 3():S47-50. PubMed ID: 12468145
[No Abstract] [Full Text] [Related]
13. Clinical, toxicological and pharmacological aspects of gemcitabine.
Guchelaar HJ; Richel DJ; van Knapen A
Cancer Treat Rev; 1996 Jan; 22(1):15-31. PubMed ID: 8625330
[No Abstract] [Full Text] [Related]
14. Role of gemcitabine in cancer therapy.
Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
[TBL] [Abstract][Full Text] [Related]
15. [First-line non-small-cell lung cancer: role of gemcitabine].
Barata F
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S20-2. PubMed ID: 16273006
[No Abstract] [Full Text] [Related]
16. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.
Banach MJ; Williams GA
Arch Ophthalmol; 2000 May; 118(5):726-7. PubMed ID: 10815173
[No Abstract] [Full Text] [Related]
17. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
18. [Severe interstitial pneumonitis related to Gemcitabine].
Sabria-Trias J; Bonnaud F; Sioniac M
Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
[TBL] [Abstract][Full Text] [Related]
19. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
Le Chevalier T; Gottfried M
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
[TBL] [Abstract][Full Text] [Related]
20. Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer.
Chen YM; Liu JM; Tsai CM; Whang-Peng J; Perng RP
J Clin Oncol; 1996 May; 14(5):1743-4. PubMed ID: 8622097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
